Ernexa Therapeutics Inc. (NASDAQ:ERNA) filed a Form 8-K with the Securities and Exchange Commission on February 11, 2026, disclosing a material event.
Ernexa Therapeutics Inc.'s stock currently trades at $0.30 with a market capitalization of $11.7M. The Healthcare company's stock moved following the disclosure.